Gregory N. Beatch

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

A. John Camm, Alessandro Capucci, Stefan H. Hohnloser et al. · Journal of the American College of Cardiology · 2011 · 272 citations

Medicine, Cardiology, Pharmacology +13

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation

Denis Roy, Brian H. Rowe, Ian G. Stiell et al. · Journal of the American College of Cardiology · 2004 · 224 citations

Medicine, Cardiology, Pharmacology +10

The Mechanism of Atrial Antiarrhythmic Action of RSD1235

David Fedida, Peter Orth, JANET Y.C. CHEN et al. · Journal of Cardiovascular Electrophysiology · 2005 · 194 citations

Medicine, Cardiology, Pharmacology +17

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial

A. John Camm, Egon Toft, Christian Torp‐Pedersen et al. · EP Europace · 2012 · 159 citations · Full text

Medicine, Cardiology, Pharmacology +17

RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents

Peter Orth, John E. Hesketh, C MAK et al. · Cardiovascular Research · 2006 · 117 citations

Medicine, Cardiology, Pharmacology +17